Historical return extremes for Spruce Biosciences (SPRB) from 2020 to 2026
What if you bought at the best or worst time? Max profit, max drawdown, and total return since IPO.
| Scenario | Return | Start date | Start price | End date | End price | $1,000 becomes |
|---|---|---|---|---|---|---|
| Max profitMore info about Max profit | +3,958% | $4.50 | $182.60 | $40,577.78 | ||
| Max drawdownMore info about Max drawdown | -99.81% | $2,431.50 | $4.50 | $1.85 | ||
| Return since IPOMore info about Return since IPO | -95.93% | $1,275 | $51.89 | $40.70 |
- Max profitMore info about Max profit+3,958%$40,577.78
- Max drawdownMore info about Max drawdown-99.81%$1.85
- Return since IPOMore info about Return since IPO-95.93%$40.70
Each row shows the start and end dates and prices for the scenario, the period return, and the resulting outcome for a $1,000 investment in Spruce Biosciences (SPRB). Max profit is the best buy-and-sell pair across the entire price history; max drawdown is the worst peak-to-trough decline; the last row tracks return from IPO to today. Prices are split- and dividend-adjusted closing prices — actual outcomes would differ due to fees, taxes, and slippage.
Frequently asked questions
Data & methodology
Spruce Biosciences (SPRB) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement